CRVSbenzinga

Corvus Pharmaceuticals Releases Data From Phase 1 Placebo-Controlled Trial Of Soquelitinib In Atopic Dermatitis Cohort 2

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on January 13, 2025 by benzinga

    Corvus Pharmaceuticals Releases Data From Phase 1 Placebo-Controlled Trial Of Soquelitinib In Atopic Dermatitis Cohort 2 | CRVS Stock News | Candlesense